What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Gene
Graham R. Foster mostly deals with Hepatitis C, Internal medicine, Hepatitis C virus, Gastroenterology and Immunology.
Graham R. Foster combines subjects such as Surgery, Hepatology, Epidemiology, Cirrhosis and Hepatitis with his study of Hepatitis C.
The concepts of his Internal medicine study are interwoven with issues in Pathology and Ribavirin, Glecaprevir.
The study incorporates disciplines such as Substance abuse and Viral load in addition to Hepatitis C virus.
His studies in Gastroenterology integrate themes in fields like Pibrentasvir, Adverse effect, Randomized controlled trial, Sofosbuvir and Simeprevir.
His study in Immunology is interdisciplinary in nature, drawing from both Transmission and Disease.
His most cited work include:
- Telaprevir for retreatment of HCV infection. (1384 citations)
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection (1320 citations)
- Interferons at age 50: past, current and future impact on biomedicine. (839 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Virology, Immunology and Ribavirin.
His Internal medicine research integrates issues from Chronic hepatitis, Sofosbuvir and Hepatitis C virus.
His research in Sofosbuvir intersects with topics in Ledipasvir and Voxilaprevir.
Graham R. Foster has researched Gastroenterology in several fields, including Hcv genotype 1, Adverse effect, Therapy naive and Genotype.
His Ribavirin research includes themes of Regimen and Pharmacology.
His work deals with themes such as Randomized controlled trial, Surgery, Hepatitis, Liver disease and Hepacivirus, which intersect with Hepatitis C.
He most often published in these fields:
- Internal medicine (50.89%)
- Gastroenterology (29.72%)
- Virology (24.38%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (50.89%)
- Gastroenterology (29.72%)
- Hepatitis C (24.20%)
In recent papers he was focusing on the following fields of study:
Graham R. Foster spends much of his time researching Internal medicine, Gastroenterology, Hepatitis C, Sofosbuvir and Hepatitis C virus.
His work carried out in the field of Internal medicine brings together such families of science as Chronic hepatitis and Ribavirin.
His Gastroenterology study integrates concerns from other disciplines, such as Liver biopsy, Tolerability, Surgery and Genotype.
His work deals with themes such as Hepatitis B, Intervention, Randomized controlled trial, Family medicine and Liver disease, which intersect with Hepatitis C.
His studies in Sofosbuvir integrate themes in fields like Elbasvir, Grazoprevir, Voxilaprevir, Grazoprevir, Ledipasvir and Elbasvir.
The study incorporates disciplines such as Interferon and Viral load in addition to Hepatitis C virus.
Between 2016 and 2021, his most popular works were:
- Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection (217 citations)
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials (159 citations)
- Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe (93 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Cancer
His scientific interests lie mostly in Internal medicine, Hepatitis C, Gastroenterology, Hepatitis C virus and Sofosbuvir.
His studies deal with areas such as Ribavirin and Drug as well as Internal medicine.
His Hepatitis C research is multidisciplinary, incorporating perspectives in Pibrentasvir, Regimen, Randomized controlled trial, Family medicine and Glecaprevir.
His study on Cirrhosis is often connected to Kynurenine pathway as part of broader study in Gastroenterology.
His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Viral load and MEDLINE.
As a member of one scientific family, Graham R. Foster mostly works in the field of Sofosbuvir, focusing on Voxilaprevir and, on occasion, Ledipasvir.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
